Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 27;9(3):199.
doi: 10.3390/vaccines9030199.

Enterovirus A71 Vaccines

Affiliations
Review

Enterovirus A71 Vaccines

Mei-Ling Li et al. Vaccines (Basel). .

Abstract

Enterovirus A71 (EV-A71) is a major causative agent of hand, foot, and mouth disease (HFMD) and herpangina. Moreover, EV-A71 infection can lead to neurological complications and death. Vaccination is the most efficient way to control virus infection. There are currently three inactivated, whole EV-A71 vaccines licensed by the China NMPA (National Medical Products Administration). Several other types of vaccines, such as virus-like particles and recombinant VP1 (capsid protein), are also under development. In this review, we discuss recent advances in the development of EV-A71 vaccines.

Keywords: Enterovirus A71; Sinovac; foot and mouth disease (HFMD); hand; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structure of the EV-A71 genome and the encoded viral proteins. The single open reading frame (ORF) is flanked by a highly structured 5′UTR and 3′UTR followed by a poly (A) tail. The 5′ end of the viral genome is covalently bound to the viral VPg protein. The ORF is divided into three regions. P1 encodes four structural (capsid) proteins, VP1–4. P2 and P3 encode seven nonstructural proteins, 2 A to 2 C and 3 A to 3 D, respectively [11].

Similar articles

Cited by

References

    1. Alexander J.P., Jr., Baden L., Pallansch M.A., Anderson L.J. Enterovirus 71 infections and neurologic disease--United States, 1977–1991. J. Infect. Dis. 1994;169:905–908. doi: 10.1093/infdis/169.4.905. - DOI - PubMed
    1. Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097–1105. doi: 10.1016/S1474-4422(10)70209-X. - DOI - PubMed
    1. Lee K.Y. Enterovirus 71 infection and neurological complications. Korean J. Pediat. 2016;59:395–401. doi: 10.3345/kjp.2016.59.10.395. - DOI - PMC - PubMed
    1. Chang L.Y., Lin H.Y., Gau S.S., Lu C.Y., Hsia S.H., Huang Y.C., Huang L.M., Lin T.Y. Enterovirus A71 neurologic complications and long-term sequelae. J. Biomed. Sci. 2019;26:57. doi: 10.1186/s12929-019-0552-7. - DOI - PMC - PubMed
    1. Puenpa J., Wanlapakorn N., Vongpunsawad S., Poovorawan Y. The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific Region. J. Biomed. Sci. 2019;26:75. doi: 10.1186/s12929-019-0573-2. - DOI - PMC - PubMed

LinkOut - more resources